IOSP Innospec
Innospec earnings company data as of 7:49 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 1.28 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by IOSP's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $25K bought by 1 insider
- $574K sold by 6 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Milton C Blackmore DirectorSale$45K 594 shares at $76.55 5.3% of stakeTraded Feb 27 Filed Mar 6
-
Claudia Poccia DirectorSale$9,110 119 shares at $76.56 1.8% of stakeTraded Feb 27 Filed Mar 6
-
Ian Cleminson CFOSale$182K 2,380 shares at $76.55 11% of stakeTraded Feb 27 Filed Mar 6
-
David B. Jones SVP, Gc & CCOSale$78K 1,028 shares at $75.64 6.5% of stakeTraded Mar 3 Filed Mar 3
-
Milton C Blackmore DirectorSale$84K 1,030 shares at $81.84 9.7% of stakeTraded Feb 20 Filed Feb 24
-
Leslie J Parrette DirectorBuy$25K 340 shares at $74.09 +6.2% to stakeTraded Nov 14, 2025 Filed Nov 17, 2025
Also filed in the last 12 months, not counted as buying or selling: 16 stock grants, 4 share withholdings for taxes, and 2 option exercises.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.